Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. | Semin Oncol | 1998 | 0.80 |
2 | Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. | Exp Hematol | 1993 | 0.80 |
3 | Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer. | Br J Haematol | 1997 | 0.79 |
4 | Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer. | Br J Cancer | 1999 | 0.76 |
5 | Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. | Bone Marrow Transplant | 1998 | 0.76 |
6 | Mobilization and selection of CD34+ cells. | Recent Results Cancer Res | 1998 | 0.75 |